CytoDyn Inc. CYDY
OTC PK
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -259.86% | -65.58% | 1.43% | -374.14% | -128.81% |
| Total Depreciation and Amortization | 375.00% | 0.00% | -20.00% | 25.00% | -20.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9,239.11% | 37.40% | 15,846.15% | 5.69% | -91.74% |
| Change in Net Operating Assets | -255.69% | 1,211.65% | -791.41% | 2,822.53% | 118.07% |
| Cash from Operations | -215.35% | 12.89% | -11.36% | -21.31% | -145.04% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 80.00% |
| Issuance of Common Stock | 58,152.38% | -3.09% | 72,842.86% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 10,209.92% | -3.09% | 77,004.76% | -- | -101.25% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 275.30% | 15.43% | 316.27% | -21.31% | -117.02% |